<table id="table10" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 10 Effect of Coadministered Agents on the Pharmacokinetics of Maraviroc</caption>
<col align="left" valign="top" width="20%"></col>
<col align="left" valign="top" width="16%"></col>
<col align="left" valign="top" width="16%"></col>
<col align="left" valign="top" width="16%"></col>
<col align="left" valign="top" width="16%"></col>
<col align="left" valign="top" width="16%"></col>
<thead>
<tr>
<th rowspan="2">Coadministered drug and dose</th>
<th rowspan="2">N</th>
<th rowspan="2">Maraviroc  Dose</th>
<th colspan="3" stylecode="Botrule">Ratio (90% CI) of maraviroc  pharmacokinetic parameters  with/without coadministered drug (no effect = 1.00)</th>
</tr>
<tr stylecode="Botrule">
<th>Cmin</th>
<th>AUC<sub>tau</sub>
</th>
<th>Cmax</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td colspan="6">
<content stylecode="bold">CYP3A and/or P-gp Inhibitors</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Ketoconazole<br/> 400 mg QD</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">100 mg BID</td>
<td stylecode="Rrule">3.75<br/> (3.01, 4.69)</td>
<td stylecode="Rrule">5.00<br/> (3.98, 6.29)</td>
<td stylecode="Rrule">3.38<br/> (2.38, 4.78)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Ritonavir<br/> 100 mg BID</td>
<td stylecode="Rrule">8</td>
<td stylecode="Rrule">100 mg BID</td>
<td stylecode="Rrule">4.55<br/> (3.37, 6.13)</td>
<td stylecode="Rrule">2.61<br/> (1.92, 3.56)</td>
<td stylecode="Rrule">1.28<br/> (0.79, 2.09)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule"> </td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Saquinavir (soft gel capsules) /ritonavir<br/> 1000 mg/100 mg BID</td>
<td stylecode="Rrule">11</td>
<td stylecode="Rrule">100 mg BID</td>
<td stylecode="Rrule">11.3<br/> (8.96, 14.1)</td>
<td stylecode="Rrule">9.77<br/> (7.87, 12.14)</td>
<td stylecode="Rrule">4.78<br/> (3.41, 6.71)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule"> </td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Lopinavir/ritonavir<br/> 400 mg/100 mg BID</td>
<td stylecode="Rrule">11</td>
<td stylecode="Rrule">300 mg BID</td>
<td stylecode="Rrule">9.24<br/> (7.98, 10.7)</td>
<td stylecode="Rrule">3.95<br/> (3.43, 4.56)</td>
<td stylecode="Rrule">1.97<br/> (1.66, 2.34)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Atazanavir<br/> 400 mg QD</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">300 mg BID</td>
<td stylecode="Rrule">4.19<br/> (3.65, 4.80)</td>
<td stylecode="Rrule">3.57<br/> (3.30, 3.87)</td>
<td stylecode="Rrule">2.09<br/> (1.72, 2.55)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Atazanavir/ritonavir<br/> 300 mg/100 mg QD</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">300 mg BID</td>
<td stylecode="Rrule">6.67<br/> (5.78, 7.70)</td>
<td stylecode="Rrule">4.88<br/> (4.40, 5.41)</td>
<td stylecode="Rrule">2.67<br/> (2.32, 3.08)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Darunavir/ritonavir<br/> 600 mg/100 mg BID</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">150 mg BID</td>
<td stylecode="Rrule">8.00<br/> (6.35, 10.1)</td>
<td stylecode="Rrule">4.05<br/> 2.94, 5.59</td>
<td stylecode="Rrule">2.29<br/> (1.46, 3.59)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="6" stylecode="Lrule Rrule">
<content stylecode="bold">CYP3A and/or P-gp Inducers</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Efavirenz<br/> 600 mg QD</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">100 mg BID</td>
<td stylecode="Rrule">0.55<br/> (0.43, 0.72)</td>
<td stylecode="Rrule">0.552<br/> (0.492, 0.620)</td>
<td stylecode="Rrule">0.486<br/> (0.377, 0.626)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Efavirenz<br/> 600 mg QD</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">200 mg BID<br/> (+efavirenz):<br/> 100 mg BID (alone)</td>
<td stylecode="Rrule">1.09<br/> (0.89, 1.35)</td>
<td stylecode="Rrule">1.15 <br/> (0.98, 1.35)</td>
<td stylecode="Rrule">1.16 <br/> (0.87, 1.55)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Rifampicin<br/> 600 mg QD</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">100 mg BID</td>
<td stylecode="Rrule">0.22<br/> (0.17, 0.28)</td>
<td stylecode="Rrule">0.368<br/> (0.328, 0.413)</td>
<td stylecode="Rrule">0.335<br/> (0.260, 0.431)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Rifampicin<br/> 600 mg QD</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">200 mg BID<br/> (+rifampicin):<br/> 100 mg BID (alone)</td>
<td stylecode="Rrule">0.66<br/> (0.54, 0.82)</td>
<td stylecode="Rrule">1.04<br/> (0.89, 1.22)</td>
<td stylecode="Rrule">0.97<br/> (0.72, 1.29)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Etravirine<br/> 200 mg BID</td>
<td stylecode="Rrule">14</td>
<td stylecode="Rrule">300 mg BID</td>
<td stylecode="Rrule">0.609<br/> (0.525, 0.707)</td>
<td stylecode="Rrule">0.468<br/> (0.381, 0.576)</td>
<td stylecode="Rrule">0.400<br/> (0.282, 0.566)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Nevirapine<footnote>
<content stylecode="bold">Compared to historical data</content>
</footnote>
<br/> 200 mg BID <br/> (+ lamivudine 150 mg BID, tenofovir 300 mg QD)</td>
<td stylecode="Rrule">8</td>
<td stylecode="Rrule">300 mg SD</td>
<td stylecode="Rrule">-</td>
<td stylecode="Rrule">1.01<br/> (0.65, 1.55)</td>
<td stylecode="Rrule">1.54<br/> (0.94, 2.51)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="6">
<content stylecode="bold">CYP3A and/or P-gp Inhibitors and Inducers</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Lopinavir/ritonavir + efavirenz<br/> 400 mg/100 mg BID + 600 mg QD</td>
<td stylecode="Rrule">11 </td>
<td stylecode="Rrule">300 mg BID</td>
<td stylecode="Rrule">6.29<br/> (4.72, 8.39)</td>
<td stylecode="Rrule">2.53<br/> (2.24, 2.87)</td>
<td stylecode="Rrule">1.25<br/> (1.01, 1.55)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Saquinavir(soft gel capsules) /ritonavir + efavirenz<br/> 1000 mg/100 mg BID + 600 mg QD</td>
<td stylecode="Rrule">11</td>
<td stylecode="Rrule">100 mg BID</td>
<td stylecode="Rrule">8.42<br/> (6.46, 10.97)</td>
<td stylecode="Rrule">5.00<br/> (4.26, 5.87)</td>
<td stylecode="Rrule">2.26<br/> (1.64, 3.11)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Darunavir/ritonavir + etravirine<br/> 600 mg/100 mg BID + 200 mg BID</td>
<td stylecode="Rrule">10</td>
<td stylecode="Rrule">150 mg BID</td>
<td stylecode="Rrule">5.27<br/> (4.51, 6.15)</td>
<td stylecode="Rrule">3.10<br/> (2.57, 3.74)</td>
<td stylecode="Rrule">1.77 <br/> (1.20, 2.60)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Tipranavir/ritonavir<br/> 500 mg/200 mg BID</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">150 mg BID</td>
<td stylecode="Rrule">1.80<br/> (1.55, 2.09)</td>
<td stylecode="Rrule">1.02<br/> (0.850, 1.23)</td>
<td stylecode="Rrule">0.86<br/> (0.61, 1.21)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">
<content stylecode="bold">Other</content>
</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Raltegravir <br/> 400 mg BID</td>
<td stylecode="Rrule">17</td>
<td stylecode="Rrule">300 mg BID</td>
<td stylecode="Rrule">0.90<br/> (0.85, 0.96)</td>
<td stylecode="Rrule">0.86<br/> (0.80, 0.92)</td>
<td stylecode="Rrule">0.79<br/> (0.67, 0.94)</td>
</tr>
</tbody>
</table>